Background: Despite the adverse effects of N-methyl-D-aspartate receptor (NMDAR) activity in cardiomyocytes, no study has yet examined the effects of NMDAR activity under ex vivo ischemicreperfusion (I/R) conditions. Therefore, our aim was to comprehensively evaluate the effects of NMDAR activity through an ex vivo myocardial I/R rat model.
INTRODUCTION
The N-methyl-D-aspartate receptor (NMDAR) is an ionotropic glutamate receptor that primarily functions as a calcium ion transporter. 1 Although previous NMDAR research has focused on its role in neuropsychiatric dysfunction, 2,3 the NMDAR has also been shown to play a key role in cerebral ischemia. 4, 5 Specifically, NMDAR activity has been shown to drive the neurotoxic calcium influx observed with cerebral ischemia. 6 Accordingly, several NMDAR blockers (eg, Cerestat, traxoprodil, remacemide, selfotel, and licostinel) have demonstrated promising neuroprotective effects in animal models of cerebral ischemia. 7 Although NMDAR research has been primarily associated with the central nervous system, Gill et al.'s group has demonstrated that NMDAR is expressed in cardiomyocytes as well. 8, 9 This discovery has led to a speculation that NMDAR may play a role in myocardial ischemia. 10 Although NMDAR activity has not been directly associated with myocardial ischemia, NMDAR activation has been shown to promote mitochondrial calcium influx and increased oxidative stress in rat cardiomyocytes-an effect that is abolished by NMDAR blockade. 11 Moreover, myocardial ischemic preconditioning has been shown to induce calcium influx and to activate downstream signaling intermediaries previously associated with CNS-expressed NMDAR, such as protein kinase C (PKC) and the mitogen-activated protein kinase extracellular signal-regulated kinase (ERK). 10, 12, 13 In addition, recent work by our research group has shown that NMDAR antagonism by MK-801 rescues the adverse effects of NMDAR-driven calcium influx in an in vitro OGD cardiomyocyte model (unpublished data).
Despite this previous evidence supporting the adverse effects of NMDAR activity in cardiomyocytes, no study has yet examined the effects of NMDAR activity under myocardial ischemic-reperfusion (I/R) conditions. We hypothesized that NMDAR-driven calcium influx potentiates the adverse effects of myocardial I/R injury. Therefore, the aim of this study was to comprehensively evaluate the effects of NMDAR activity through an ex vivo myocardial I/R rat model.
MATERIALS AND METHODS

Ethics Statement
This study was conducted according to the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals. 14 The study protocols involving animal subjects were approved in advance by the Animal Ethics Committee of the Gannan Medical University (approval no. 201233). All efforts were made to minimize animal suffering.
Preparation of Isolated Rat Hearts
Isolated rat hearts were prepared as previously described by Hu et al with minor modifications. 15 One hundred adult male Sprague-Dawley rats (weight range: 200-250 g) were first injected with sodium pentobarbital (50 mg/kg intraperitoneally) followed by injection with heparin (50 IU intravenously). Then, the rat hearts were rapidly dissected out of their thoracic cavities and gently put in ice-cold (48C) Krebs-Henseleit buffer solution (118 mM NaCl, 25 mM NaHCO 3 , 11 mM glucose, 4.7 mM KCl, 1.25 mM CaCl 2 , 1.2 mM KH 2 PO 4 , and 1.2 mM MgSO 4 ; pH 7.4). The rat hearts were then positioned on a Langendorff instrument for perfusion as described below.
Construction of Ex Vivo Global Myocardial I/R Model
The isolated rat hearts were randomly segregated into 6 groups (n = 20 in each group): (1) an untreated healthy control group (the control group); (2) a NMDA-treated control group (the NMDA group); (3) an untreated I/R group (the I/R group); (4) an NMDA-treated I/R group (the I/R+NMDA group); (5) a NMDA-treated and MK-801-treated I/R group (the I/R+NMDA+MK-801 group), and (6) a [Ca 2+ ]-free, NMDA-treated I/R group (the I/R+NMDA+[Ca 2+ ]-free group) (Fig. 1) . The isolated rat hearts underwent baseline equilibration with gas-infused Krebs-Henseleit buffer (95% O 2 , 5% CO 2 ) at 80 mm Hg pressure for a 20-minute period (378C). Then, the isolated rat hearts were treated according to their respective grouping for a period of 10 minutes as follows (all 378C): (1) the control group was left untreated on the gas-infused Krebs-Henseleit buffer; (2) the NMDA group was treated with 0.1 mM NMDA in the gas-infused KrebsHenseleit buffer; (3) the I/R group was left untreated on the gas-infused Krebs-Henseleit buffer; (4) the I/R+NMDA group was treated with 0.1 mM NMDA in the gas-infused Krebs-Henseleit buffer; (5) the I/R+NMDA+MK-801 was treated with 0.1 mM NMDA and 30 mM MK-801 in the gasinfused Krebs-Henseleit buffer; and (6) the I/R+NMDA +[Ca 2+ ]-free group was treated with 0.1 mM NMDA and [Ca 2+ ]-free, gas-infused Krebs-Henseleit buffer solution. The dosages of 0.1 mM NMDA and 30 mM MK-801 applied here are based on previous research in neonatal rat cardiomyocytes by Gao et al 11 After the 10-minute treatment period, the rat hearts in the 4 I/R groups (ie, the I/R group, I/R+NMDA group, I/R +NMDA+MK-801, and the I/R+NMDA+[Ca 2+ ]-free group) underwent global myocardial I/R by ceasing the KrebsHenseleit perfusion for 30 minutes (ischemia) immediately followed by reperfusion for 50 minutes (378C), as previously described by Hu et al 15 Reperfusion was performed using the same solutions applied during the 10-minute treatment period (see above). The control groups were not subjected to I/R and were left on the gas-infused Krebs-Henseleit buffer.
Ventricular Pressure Measurement
As previously described by Hu et al, 15 saline-fillable latex balloon was threaded through the left atrial chamber and the mitral valve into the left ventricular chamber. Then, the balloon was inflated to reach a left ventricular enddiastolic pressure (LVEDP) of less than 10 mm Hg. The left ventricular developed pressure (LVDP) as well as the maximal rates of LVDP gains (+dP/dt) and losses (2dP/dt) were measured through a MP150 pressure transducer (BIOPAC FIGURE 1. Experimental overview: 6 groups (n = 20 each) were constructed to assess the effects of NMDAR-driven influx: (1) a control group, (2) a NMDA group, (3) an I/R group; (4) an I/R+NMDA group; (5) an I/R+NMDA+MK-801 group, and (6) 16 Then, the isolated ventricular cardiomyocytes were treated in a fura-2 AM buffer (5 mM fura-2 AM with 1 mM Ca 2+ , pH 7.4) for 40 minutes. The cells were then rinsed twice to remove excess dye. For standardization, the cell density within the cuvette was set to 300,000 cells/mL per experimental group. Fluorescent intensities were measured with a dual-wavelength spectrofluorometer (RF-5000, Shimadzu Corporation, Kyoto, Japan) using the following parameters: 340/380-nm excitation wavelength, 510-nm emission wavelength, 0.95-s integration time, and 1.0-s resolution time. [Ca 2+ ] i levels were assessed with the Grynkiewicz formula as follows 17 
, where R is the fluorescence signal ratio derived from 340-nm and 380-nm excitation wavelengths, R max and R min are the R values after adding 10% Triton X-100 (20 mL) and 400 mM EGTA (40 mL), respectively, and Sf 2 and Sb 2 are the fluorescence proportionality coefficients (measured at a 380-nm excitation wavelength) obtained under R min and R max conditions, respectively.
Cardiac Marker Assays
Creatine kinase (CK), creatine kinase isoenzyme MB (CK-MB), lactate dehydrogenase (LDH), cardiac troponin I (cTnI), and cardiac troponin T (cTnT) levels were assayed as previously described by Hu et al with minor modifications. 15 Coronary effluents were collected immediately after the 20-minute baseline equilibration period and immediately after the 50-minute reperfusion period. Activity levels for all 5 cardiac markers were assayed spectrophotometrically using their respective kits according to the kits' instructions (Jiancheng Reagent Co, Nanjing, China). Activity levels of all 5 cardiac markers were calculated using their respective standard curves.
Assessment of Generalized Myocardial Necrosis
As previously described by Hu et al, 15 staining with 2,3,5-triphenyltetrazolium chloride (TTC; Sigma Chemical, St. Louis, MO) was used to measure generalized myocardial necrosis. Immediately after the aforementioned 50-minute reperfusion period, the rat hearts were frozen to 2208C for 3 hours. The resulting frozen ventricular tissue was sliced into sections (2-3 mm) and then incubated in 1% TTC dissolved in 0.1 M Tris buffer (pH 7.8) at 378C for 15 minutes. Slices were captured by digital photography followed by imaging analysis with Image 1.38 (NIH, Bethesda, MD). Generalized myocardial necrosis was measured as the proportion of the sectioned area.
Apoptosis Assay
As previously described by Hu et al, 15 the one step terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) apoptosis assay kit (Beyotime Biotechnology, Haimen, Jiangsu, China) was used to assay apoptosis levels in the ventricular tissue sections. A TUNEL stain (green fluorescent dye; Beyotime Biotechnology) was applied to identify apoptotic cells, whereas 6-diamino-2-phenylindole (DAPI) stain (blue fluorescent dye; Beyotime Biotechnology) was applied to identify all cardiomyocytes. Fluorescence microscopy (Olympus IX81, Tokyo, Japan) was used to perform cellular counts. Ten visual fields were randomly chosen for each sample.
Western Blotting of Protein Kinases
As previously described by Hu et al, 15 total protein (30 mg from each sample) was separated by sodium doecyl sulfate polyacrylamide gel electrophoresis with 8% acrylamide gels used for total PKC-d, p-PKC-d(Ser 643 ), total PKC-e, and p-PKC-e(Ser 729 ), and 10% acrylamide gel was used for total Akt, p-Akt(Ser 473 ), p-Akt(Thr 308 ), total ERK, and p-ERK (Thr 402 -Tyr 204 ). After transfer onto polyvinylidene difluoride membranes, the membranes were then subjected to overnight incubation at 48C with the following primary antibodies ( 
Statistical Analysis
Results were expressed as mean and associated standard errors of the mean (SEMs). Comparisons between 2 groups were conducted by Student's t-testing, whereas comparisons between more than 2 groups were conducted by 2-way analysis of variance. A P value of , 0.05 was deemed significant.
RESULTS
We first assessed myocardial intracellular calcium levels ([Ca 2+ ] i ) over the 50-minute reperfusion period to examine the effect of NMDAR activity on myocardial calcium influx. NMDA treatment under control conditions had no significant effect on [Ca 2+ ] i (P . 0.05, Fig. 2 ). After global myocardial I/R, there was a significant elevation in [Ca 2+ ] i relative to control conditions (;17% increase, P , 0.05, Fig. 2) . Notably, treatment with NMDA under I/R conditions produced a slightly more pronounced elevation in decrease, P , 0.05, Fig. 3B ), and 2dp/dt min (;43% decrease, P , 0.05, Fig. 3C ), relative to control conditions. Notably, treatment with NMDA under I/R conditions produced more significant reductions in LVDP (additional ;5.4% decrease, P , 0.05, Fig. 3A) , +dp/dt max (additional ;5.4% decrease, P , 0.05, Fig. 3B ), and 2dp/dt min (additional ;5.8% decrease, P , 0.05, Fig. 3C ). Treatment with MK-801 or [Ca 2+ ]-free buffer rescued these damaging effects of NMDA under I/R conditions (all P , 0.05, Fig. 3) .
Next, we assessed the coronary effluent activity of 5 key cardiac markers (ie, CK, CK-MB, LDH, cTnI, and cTnT) to examine the extent of myocardial damage. NMDA treatment under control conditions had no significant effect on the 5 key cardiac markers (P . 0.05, Fig. 4) . After global myocardial I/R, there were significant multi-fold increases in CK (P , 0.05, Fig. 4A ), CK-MB (P , 0.05, Fig. 4A ), LDH (P , 0.05, Fig. 4A ), cTnI (P , 0.05, Fig. 4B ), and cTnT (P , 0.05, Fig. 4B ), relative to control conditions. Notably, treatment with NMDA under I/R conditions produced more significant multi-fold increases in all 5 cardiac markers (all P , 0.05, Fig. 4 ). Treatment with MK-801 or [Ca 2+ ]-free buffer rescued the elevated levels of all 5 cardiac markers (P , 0.05, Fig. 4 ).
Isolated rat hearts initially display myocardial apoptosis after 10 minutes of ischemia and achieve a maximal level of myocardial apoptosis after 30 minutes of ischemia. 18 Accordingly, the global myocardial I/R model applied here (ie, a 30-min period of global myocardial ischemia followed by a reperfusion period) has been shown to reliably produce generalized myocardial necrosis in isolated rat hearts. 15, [19] [20] [21] Using this ex vivo model, we assessed the degree of generalized myocardial necrosis and cardiomyocyte apoptosis by the TTC-based staining (Fig. 5A) and TUNEL-based staining, respectively. NMDA treatment under control conditions had no significant effect on generalized myocardial necrosis (P . 0.05, Fig. 5B ) or cardiomyocyte apoptosis (P . 0.05, Fig. 5C ). After global myocardial I/R, there was a significant multi-fold increase in generalized myocardial necrosis (P , 0.05, Fig. 5B ) as well as a significant increase in cardiomyocyte apoptosis levels relative to control conditions (;130% increase, P , 0.05, Fig. 5C ). Notably, treatment with NMDA under I/R conditions produced more significant increases in generalized myocardial necrosis (;36% increase, P , 0.05, Fig. 5B ) and cardiomyocyte apoptosis (;150% increase, P , 0.05, Fig. 5C ). Treatment with MK-801 or [Ca 2+ ]-free buffer rescued these damaging effects of NMDA under I/R conditions (both P , 0.05, Fig. 5B, C) . Finally, we applied Western blotting to assess the phosphorylation of 4 protein kinases that have been previously associated with myocardial ischemia and ischemic cardioprotection (ie, PKC-d, PKC-e, Akt, and ERK). [22] [23] [24] NMDA treatment under control conditions had no significant effect on the activation of the 4 protein kinases (all P . 0.05, Fig. 6 ). After global myocardial I/R, there were significant increases in the phosphorylation of PKC-d (P , 0.05, Fig. 6A ), PKC-e (P , 0.05, Fig. 6B ), Akt(Ser 473 ) and Akt (Thr 308 ) (both P , 0.05, Fig. 6C ), and ERK (P , 0.05, Fig. 6D ) relative to control conditions. Notably, treatment with NMDA under I/R conditions produced more significant multi-fold increases in the phosphorylation of all 4 protein kinases (all P , 0.05, Fig. 6 ). Treatment with MK-801 or [Ca 2+ ]-free buffer rescued the elevated phosphorylation levels of all 4 protein kinases (all P , 0.05, Fig. 6 ).
DISCUSSION
The objective of this study was to comprehensively evaluate the effects of NMDAR activity through an ex vivo global myocardial I/R rat model. We found that enhanced NMDAR activity (through NMDA treatment) under I/R conditions produces significant increases in [Ca 2+ ] i levels, significant losses in left ventricular function, significant increases in markers of myocardial damage, significant increases in generalized myocardial necrosis and cardiomyocyte apoptosis, and significant increases in the phosphorylation of PKC-d, PKC-e, Akt, and ERK. These adverse effects were rescued by either treatment with the NMDAR inhibitor MK-801 or [Ca 2+ ]-free buffer. In contrast, enhanced NMDAR activity under control conditions had no significant effects on the foregoing variables. These combined findings indicate that NMDAR-driven calcium influx potentiates the adverse effects of myocardial I/R injury ex vivo.
Our findings show that NMDAR activity under I/R conditions promotes myocardial calcium influx. Consistent with our findings, previous studies on rodent I/R heart models have demonstrated that a 30-minute period of global myocardial ischemia followed by a reperfusion period results in significant increases in [Ca 2+ ] i . 25, 26 Interestingly, these same studies also demonstrate no significant changes in [Ca 2+ ] i levels for ischemic periods under 30 minutes in duration. 25, 26 As ischemic damage in murine and rodent hearts is fully reversible on reperfusion after ischemic periods of less than 30 minutes, Saini et al has postulated that the increased [Ca 2+ ] i levels found in I/R heart models after 30 minutes of ischemia may be exclusively linked to conditions of irreversible myocardial ischemic injury. 16 On this basis, our current findings suggest that NMDAR activity potentiates myocardial calcium influx solely under conditions of irreversible myocardial ischemic injury. Further studies on NMDAR activity involving myocardial ischemic periods of less than 30 minutes are needed to verify this hypothesis.
Our findings show that NMDAR-driven calcium influx adversely affects myocardial performance under I/R conditions, as demonstrated by (1) the significant increase in [Ca 2 + ] i levels coupled with (2) the significant LVDP reduction in NMDA-treated hearts under I/R conditions, both of which were rescued by treatment with MK-801 or [Ca 2+ ]-free buffer. Moreover, our data revealed that this NMDAR-driven calcium influx under I/R conditions results in a less significant 2dP/dt min during I/R. As 2dP/dt correlates with sarcoplasmic reticulum calcium re-uptake, NMDAR-driven calcium influx likely promotes SR calcium-ATPase activity as well as slower ventricular relaxation under I/R conditions. 27 Thus, according to the Frank-Starling relationship, NMDAR-driven calcium influx under I/R conditions may also result in a less significant end-diastolic volume as well as lessened ventricular force production. 27 Notably, NMDAR activation under control conditions had no significant effect on LVDP, +dp/dt max , or 2dp/dt min . This concords with previous findings by Shi et al in adult rats, who showed that chronic intraperitoneal NMDA therapy (3 mg$ml 21 $kg 21 ) produces no significant effects on key cardiac function parameters (ie, fractional shortening, left ventricular end-diastolic and endsystolic dimensions, left ventricular ejection fraction). 28 As extracellular levels of the NMDA agonists, glutamate and aspartate, have been shown to rise in the myocardium during I/R, 29, 30 our current findings suggest that the presence of I/R-induced NMDAR stimulants other than NMDA may be necessary to drive the NMDAR-gated [Ca 2+ ] overload required to significantly disrupt cardiac function. 31 Our findings also show that NMDAR-driven calcium influx adversely affects myocardial survival under I/R conditions, as demonstrated by the significant increases in myocardial damage markers, generalized myocardial necrosis, and apoptosis levels in NMDA-treated hearts that was rescued by treatment with MK-801 or [Ca 2+ ]-free buffer. Consistent with the present findings, previous in vivo CNS research has shown that blocking NMDAR activity or disrupting downstream NMDAR signaling activity results in reduced postischemic cerebral infarct size. [32] [33] [34] This NMDAR-driven cerebral damage has been attributed to the calcium influx by pannexin hemichannels and TRPVM7 channels. 35, 36 Therefore, although this is the first study to demonstrate that NMDAR-driven calcium influx potentiates the adverse effects of myocardial I/R injury ex vivo, it is possible that NMDAR activity also promotes the activation of other calcium channels that may contribute to the observed effects. For instance, previous research in OGD cardiomyocytes suggests that hemichannel-based calcium influx occurs during the first hour of ischemia, whereas other types of calcium influx (eg, L/T-type channels, sodium/calcium exchangers, and intracellular release channels) seem to dominate during the second hour of ischemia. 37 Future research should examine NMDAR's effects on the range of myocardial calcium channel types to further investigate this issue.
To examine downstream protein kinase activity associated with NMDAR-driven calcium influx, we assessed the phosphorylation levels of 4 protein kinases, which have been previously linked to myocardial ischemia and ischemic cardioprotection: PKC-d, PKC-e, Akt, and ERK. [22] [23] [24] PKC family isoforms act as downstream signal transduction intermediaries of phospholipase C/D-driven diacylglycerol signaling. 38 In particular, the PKC-d and PKC-e isoforms have been associated with myocardial I/R. [39] [40] [41] [42] Specifically, PKC-d and PKC-e have been shown to activate and translocate in both cultured cardiomyocytes and isolated rat hearts under brief I/R conditions. 23, 41 Here, we found that NMDAR-driven calcium influx increased PKC-d and PKC -e phosphorylation levels under I/R conditions, indicating that NMDAR-driven calcium influx potentiates the PKCd/e-activating effects of myocardial I/R. However, as PKCd and PKC-e phosphorylation are DAG-dependent and are not calcium dependent, 43 the increased levels of PKC-d and PKC-e phosphorylation seen here cannot be directly attributed to NMDAR-driven calcium influx but may result from increased phospholipase C/D-driven DAG synthesis from calcium influx-induced ROS generation. 44 Akt is a cardioprotective protein kinase, which is activated under I/R conditions, where it serves to block cardiomyocyte apoptosis. 45, 46 For instance, gains in Akt (Ser 473 ) and Akt(Thr 308 ) phosphorylation have been positively linked with myocardial I/R in ex vivo isolated heart models. [47] [48] [49] [50] Here, NMDAR-driven calcium influx enhanced Akt(Ser 473 ) and Akt(Thr 308 ) phosphorylation under I/R conditions, indicating that NMDAR-driven calcium influx potentiates the Akt-activating effects of myocardial I/R. As Akt activation provides a cardioprotective effect under I/R conditions; 45, 46 the increased Akt phosphorylation observed in NMDA-treated hearts here may reveal an Akt-based protective feedback mechanism against the pro-apoptotic effects of NMDAR-driven calcium influx.
Similar to Akt, ERK is also a cardioprotective protein kinase, which is activated under I/R conditions. 51 Specifically, previous findings in cultured cardiomyocytes and isolated rat hearts under I/R conditions have shown that ERK activation promotes cardiomyocyte survival by counteracting JNK and p38-induced apoptosis. 51 As ERK activation provides a protective effect against cardiomyocyte apoptosis under I/R conditions, 51 the increased ERK phosphorylation observed in NMDA-treated hearts here may represent a protective feedback mechanism against the pro-apoptotic effects of NMDAR-driven calcium influx.
There are several limitations to this study. First, this study's findings were limited to an ex vivo isolated rat heart model. Thus, our findings may not be directly translatable to in vivo myocardial I/R injury in humans. Second, we did not assess whether the rescue effect of inhibiting NMDAR by MK-801 would be as effective if applied during I/R as opposed to before I/R. Third, although we demonstrated that NMDAR-driven calcium influx promotes PKC-d, PKC-e, Akt, and ERK phosphorylation under I/R conditions, it is possible that other signaling effectors are influenced by NMDAR-induced calcium influx as well. Thus, future research should investigate changes in other signaling pathways related to myocardial I/R injury, such as p38 mitogenactivated protein kinase, JNK, Src, and Lck (23) . Fourth, NMDAR knockdown and overexpression experiments were not conducted here. Thus, future investigations should apply these molecular techniques to validate our conclusions.
In conclusion, NMDAR-driven calcium influx under I/R conditions produces significant increases in [Ca 2+ ] i levels, significant losses in left ventricular function, significant increases in markers of myocardial damage, significant increases in generalized myocardial necrosis and cardiomyocyte apoptosis, and significant increases in the phosphorylation of PKC-d, PKC-e, Akt, and ERK. As NMDAR-driven calcium influx adversely influences cardiac performance and myocardial survival under I/R conditions, these findings suggest that NMDAR antagonism may be an effective ancillary therapeutic strategy for myocardial I/R injury.
